Biomarker for anti-tumor therapy Vlaams Instituut voor Biotechnologie
The invention relates to the field of biomarkers useful in monitoring anti-tumor therapy response. In particular, the biomarker identified herein is a plexin of the A-class. More in particular expression of a plexin of the A-class in circulating T-cells is an early non-invasive biomarker for response to anti-tumor therapy. Methods of using this biomarker as well as kits relying on this biomarker are part of the invention.